Article
The Safety and Efficacy of Ramosetron versus Psyllium for the Treatment of Fecal Incontinence (SERAFI) : Study protocol for a randomized trial
2025-05-15
Abstract excerpt
<title>Abstract</title> <p> <bold>Background</bold> : Fecal incontinence (FI) is a prevalent condition affecting 2% to 21% of the general population, with higher rates in older adults and specific settings such as nursing homes and hospitals. Current treatments include supportive care, biofeedback, anal injections, and sacral nerve stimulation, though these can be invasive or costly. Pharmacological therapies,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e50e20bf-7bfc-5df0-aba3-0e9a1b807925
- DOI
- 10.21203/rs.3.rs-5153650/v1
